Direxion Daily S&P Biotech Bull 3x Shares (LABU) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free LABU Stock Alerts $89.47 -2.51 (-2.73%) (As of 03:39 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Up 3.3%americanbankingnews.com - April 21 at 3:12 AMDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Trading Down 4.8%americanbankingnews.com - April 14 at 5:32 AMThe 3 Best Leveraged ETFs for April 2024investorplace.com - April 2 at 3:11 PMDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1606msn.com - March 21 at 6:21 PMLABU: A Really Bad Driftseekingalpha.com - March 4 at 8:10 AMDirexion Daily S&P Biotech Bull 3X Shares (LABU)finance.yahoo.com - January 22 at 12:59 PMLABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)seekingalpha.com - December 16 at 9:39 AMLABU: Tool For Swing Tradersseekingalpha.com - December 10 at 1:01 PMUVXY, LABU and NAIL among weekly ETF moversmsn.com - November 4 at 3:25 PMDirexion Announces Reverse Splits of TMF and LABUfinance.yahoo.com - November 3 at 6:16 PMLABU And LABD: Another Attractive Double-Short Pairs Trademsn.com - September 29 at 7:49 PMDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.0020msn.com - September 20 at 3:12 PMLABU: A Levered ETF Doomed From The Startmsn.com - August 20 at 5:57 PMUnusual Call Option Trade in Direxion Daily S&P Biotech Bull 3X Shares (LABU) Worth $124.42Kmsn.com - May 12 at 12:27 AMUnusual Call Option Trade in Direxion Daily S&P Biotech Bull 3X Shares (LABU) Worth $162.00Kmsn.com - April 25 at 8:53 PMDirexion Daily Software Bull 2X Shares declares quarterly distribution of $0.0070msn.com - March 24 at 1:23 PMWant Diversified Upside in Biotechnology? Check out LABUmarketbeat.com - March 22 at 9:00 AMLABU: Leveraged Biotech ETF Reviewseekingalpha.com - January 31 at 6:49 PMHow to Trade the High-Growth Biotech Sector in the Midst of a Bear Marketbenzinga.com - November 23 at 8:58 AMLABU: Opportunities For Gains Exist If Bought And Sold At Correct Priceseekingalpha.com - October 29 at 4:44 AMDirexion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU.MX)ca.finance.yahoo.com - August 9 at 10:09 PMDirexion Daily S&P Biotech Bull 3X Shares Newsthestreet.com - July 2 at 8:58 PMTaking On Volatility With Geared ETFsfinance.yahoo.com - February 8 at 5:30 PMWhy Moderna Stock Needs To Hold This Support Levelbenzinga.com - November 4 at 12:48 AM Get Direxion Daily S&P Biotech Bull 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABU and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here LABU Media Mentions By Week LABU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABU News Sentiment▼1.110.51▲Average News Sentiment LABU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABU Articles This Week▼10▲LABU Articles Average Week Get Direxion Daily S&P Biotech Bull 3x Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for LABU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: iShares U.S. Pharmaceuticals ETF News Today VanEck Pharmaceutical ETF News Today VanEck Biotech ETF News Today Invesco Pharmaceuticals ETF News Today Invesco Biotechnology & Genome ETF News Today Invesco S&P SmallCap Health Care ETF News Today SPDR S&P Pharmaceuticals ETF News Today Simplify Health Care ETF News Today ALPS Medical Breakthroughs ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:LABU) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
